Abu Dhabi partners with US biotech firm to advance gene-editing therapies 25.06.2026

Abu Dhabi has taken another major step in advancing precision medicine after the Department of Health – Abu Dhabi (DoH), M42, and US-based Mammoth Biosciences signed a memorandum of understanding (MoU) at the BIO International Convention 2026 in San Diego. The collaboration aims to develop gene-editing therapies for rare and inherited diseases by building on Abu Dhabi's ongoing investments in genomics and the Emirati Genome Programme. Officials stated that the goal is to translate genetic research into treatments benefiting patients in the UAE and globally.

Gulf News Full Article














